Personnel

Plattner named head of research at anti-infectives pharmaceutical firm

Published in Drug Week, April 2nd, 2004

Anacor Pharmaceuticals, an early-stage pharmaceutical company engaged in the discovery and development of novel anti-infectives for the treatment of serious infections caused by bacteria, fungi, viruses and parasites, announced that Jacob J. Plattner, PhD, has joined the company as senior VP of Research and Development.

Plattner will focus on the continued development of technology initially created by Anacor Co-Founders Lucy Shapiro at Stanford University and Stephen Benkovic at Pennsylvania State University. Anacor is using this research base to develop drugs for relevant biowarfare pathogens such as anthrax and tularemia, hospital infections caused by staphylococcus...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2004-04-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry